<div id="readability-page-1">Ekso Bionics (EKSO) on Wednesday said it entered into securities purchase agreements on Jan. 20, 2026, with institutional and accredited investors for a private placement of 5,852 shares of Series B preferred stock and warrants to buy up to 0.36M common shares. Each preferred share has a stated value of $1,000 and may be converted at any time into ...</div>

<p>Ekso Bionics (EKSO) announced a private placement of $5.8 million on January 20, 2026, involving 5,852 shares of Series B preferred stock and warrants for up to 360,000 common shares. Each preferred share is valued at $1,000 and can be converted into common shares at any time.</p>

SPDR S&P Biotech

SPDR S&P Health Equip

iShares Biotechnology ETF

First Trust NYSE Arca Biotech Index Fd

VanEck Biotech ETF

EKSO Bionics

Direxion S&P Biotech Bear 3X

Invesco Biotechnology & Genome ETF

Proshares Ultra Nasdaq Biotech

ALPS Medical Breakthrough

iShares US Medical Devices

Ekso Bionics prices $5.8M private placement